# C_2011025EN.01002501.xml

| 27.1.2011 | EN | Official Journal of the European Union | C 25/25 |
| --- | --- | --- | --- |

27.1.2011

EN

Official Journal of the European Union

C 25/25

---

Prior notification of a concentration

(Case COMP/M.6103 — CVC/Capio Sanidad)

Candidate case for simplified procedure

(Text with EEA relevance)

2011/C 25/05

| 1. | On 19 January 2011, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which CVC Capital Partners European Equity Fund V (‘CVC Fund V’, Jersey Island), ultimately controlled by CVC Capital Partners SICAV-FIS SA (‘CVC’, Luxembourg), acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of Capio Sanidad S.L. (‘Capio’, Spain) by way of purchase of shares. |
| --- | --- |

1.

On 19 January 2011, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which CVC Capital Partners European Equity Fund V (‘CVC Fund V’, Jersey Island), ultimately controlled by CVC Capital Partners SICAV-FIS SA (‘CVC’, Luxembourg), acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of Capio Sanidad S.L. (‘Capio’, Spain) by way of purchase of shares.

1

| 2. | The business activities of the undertakings concerned are:






  — | for CVC Fund V: investment fund advised by CVC, a private equity firm, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for CVC Fund V: investment fund advised by CVC, a private equity firm,

| — | for Capio: provision of private healthcare services in Spain. |
| --- | --- |

—

for Capio: provision of private healthcare services in Spain.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the EC Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the EC Merger Regulation (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the EC Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the EC Merger Regulation (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

2

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.6103 — CVC/Capio Sanidad, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| J-70 |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.6103 — CVC/Capio Sanidad, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

J-70

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘EC Merger Regulation’).

1

(2)  OJ C 56, 5.3.2005, p. 32 (‘Notice on a simplified procedure’).

2

---